# Respiratory Virus Metagenomics After COVID-19

> **NCT05126589** · — · RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 500 (estimated)

## Conditions studied

- COVID-19 Respiratory Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05126589
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-28
- **Primary completion:** 2026-07
- **Final completion:** 2027-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05126589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05126589, "Respiratory Virus Metagenomics After COVID-19". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05126589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
